Literature DB >> 495152

Conversion of arachidonic acid to prostaglandins in homogenates of human skeletal muscle and kidney.

T Berlin, R Cronestrand, J Nowak, T Sonnenfeld, A Wennmalm.   

Abstract

The capacity of human skeletal muscle and kidney homogenates to synthetize prostaglandins (PGs) from exogenous precursor was investigated. Low-speed supernatants of muscle as well as renal medullary and cortical homogenates were incubated with 14C-labelled arachidonic acid (14C-AA) prepared as a sodium salt. 14C-PGs in the incubates were extracted, separated with thin-layer chromatography (TLC) and quantified by radioscanning. In the skeletal muscle incubates 14C-AA was converted into 14C-PGs with a time-dependent yield, most effectively after 10--15 min incubation. Well-defined radiopeaks parallel to unlabelled standards of PGD2, PGE2, PGF2 alpha and 6-keto-PGF1 alpha were obtained in the chromatograms. PGE2 was the main PG formed, constituting over 50% of 14C-activity, whereas 6-keto-PGF1 alpha, PGD2 and PGF2 alpha were found in considerably lower proportions. In the renal medullary incubates, PGE2 likewise accounted for the largest part of 14C-PGs formed, but significant relative amounts of PGF2 alpha and PGD2 were also found. A minor peak, corresponding to 6-keto-PGF1 alpha and thus indicating formation of PGI2, was also obtained. In contrast to the medulla, no 14C-PGs could be found in the renal cortical incubates. The results demonstrate the existence of a considerable tissue specificity in the quantitative and qualitative expression of PG biosynthesis in man.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 495152     DOI: 10.1111/j.1748-1716.1979.tb06424.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  10 in total

1.  PPADS does not block contraction-induced prostaglandin E2 synthesis in cat skeletal muscle.

Authors:  Jennifer L McCord; Shawn G Hayes; Marc P Kaufman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-12       Impact factor: 4.733

2.  Aspirin as a COX inhibitor and anti-inflammatory drug in human skeletal muscle.

Authors:  Stephen M Ratchford; Kaleen M Lavin; Ryan K Perkins; Bozena Jemiolo; Scott W Trappe; Todd A Trappe
Journal:  J Appl Physiol (1985)       Date:  2017-07-13

Review 3.  The skeletal muscle arachidonic acid cascade in health and inflammatory disease.

Authors:  Marina Korotkova; Ingrid E Lundberg
Journal:  Nat Rev Rheumatol       Date:  2014-01-28       Impact factor: 20.543

4.  Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor.

Authors:  Y Guan; Y Zhang; R M Breyer; B Fowler; L Davis; R L Hébert; M D Breyer
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

5.  Endoperoxide 4 receptors play a role in evoking the exercise pressor reflex in rats with simulated peripheral artery disease.

Authors:  Katsuya Yamauchi; Joyce S Kim; Audrey J Stone; Victor Ruiz-Velasco; Marc P Kaufman
Journal:  J Physiol       Date:  2013-04-08       Impact factor: 5.182

6.  Effect of sleep deprivation on cholesterol metabolism and triglyceridaemia in male volunteers.

Authors:  K Vondra; V Brodan; M Dobiásová; V Vítek; J Kopecká
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

Review 7.  Role of Redox Signaling and Inflammation in Skeletal Muscle Adaptations to Training.

Authors:  Maria Carmen Gomez-Cabrera; Jose Viña; Li Li Ji
Journal:  Antioxidants (Basel)       Date:  2016-12-13

8.  No effect of endoperoxide 4 or thromboxane A2 receptor blockade on static mechanoreflex activation in rats with heart failure.

Authors:  Alec L E Butenas; Korynne S Rollins; Jacob E Matney; Auni C Williams; Talyn E Kleweno; Shannon K Parr; Stephen T Hammond; Carl J Ade; Karen S Hageman; Timothy I Musch; Steven W Copp
Journal:  Exp Physiol       Date:  2020-10-06       Impact factor: 2.969

Review 9.  Effects of prostaglandins and COX-inhibiting drugs on skeletal muscle adaptations to exercise.

Authors:  Todd A Trappe; Sophia Z Liu
Journal:  J Appl Physiol (1985)       Date:  2013-03-28

10.  Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis.

Authors:  M Korotkova; S Barbasso Helmers; I Loell; H Alexanderson; C Grundtman; C Dorph; I E Lundberg; P-J Jakobsson
Journal:  Ann Rheum Dis       Date:  2007-12-18       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.